Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen J Forman

Showing results (191-200 of 500) with videos related to

Pageof 50
Sort By:
Leukemia & Lymphoma|June 25, 2011
Allogeneic hematopoietic cell transplant for peripheral T-cell non-Hodgkin lymphoma results in long-term disease controlJasmine Zain, Joycelynne M Palmer, Maria Delioukina, et al.
Blood Advances|July 25, 2018
Prediction of cardiovascular disease among hematopoietic cell transplantation survivorsSaro H Armenian, Dongyun Yang, Jennifer Berano Teh, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 18, 2012
Second primary malignancies after autologous hematopoietic cell transplantation for multiple myelomaAmrita Y Krishnan, Matthew Mei, Can-Lan Sun, et al.
Plos One|January 14, 2016
L1 Cell Adhesion Molecule-Specific Chimeric Antigen Receptor-Redirected Human T Cells Exhibit Specific and Efficient Antitumor Activity against Human Ovarian Cancer in MiceHao Hong, Christine E Brown, Julie R Ostberg, et al.
Blood Cancer Journal|July 12, 2023
Donor-derived CD19-targeted chimeric antigen receptor T cells in adult transplant recipients with relapsed/refractory acute lymphoblastic leukemiaIbrahim Aldoss, Samer K Khaled, Yan Wang, et al.
Blood|October 5, 2012
Cardiovascular risk factors in hematopoietic cell transplantation survivors: role in development of subsequent cardiovascular diseaseSaro H Armenian, Can-Lan Sun, Tabitha Vase, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 21, 2007
Phase II trial of a transplantation regimen of yttrium-90 ibritumomab tiuxetan and high-dose chemotherapy in patients with non-Hodgkin's lymphomaAmrita Krishnan, Auayporn Nademanee, Henry C Fung, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 1, 2014
Autologous transplantation for transformed non-Hodgkin lymphoma using an yttrium-90 ibritumomab tiuxetan conditioning regimenMatthew Mei, Marielle J Wondergem, Joycelynne M Palmer, et al.
Bone Marrow Transplantation|April 5, 2022
Genome-wide variants and polygenic risk scores for cognitive impairment following blood or marrow transplantationNoha Sharafeldin, Jianqing Zhang, Purnima Singh, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 8, 2017
Next-Generation Sequencing in Adult B Cell Acute Lymphoblastic Leukemia PatientsOlga Sala Torra, Megan Othus, David W Williamson, et al.
Pageof 50

Showing results (191-200 of 500) with videos related to

Sort By:
Pageof 50
Leukemia & Lymphoma|June 25, 2011
Allogeneic hematopoietic cell transplant for peripheral T-cell non-Hodgkin lymphoma results in long-term disease controlJasmine Zain, Joycelynne M Palmer, Maria Delioukina, et al.
Blood Advances|July 25, 2018
Prediction of cardiovascular disease among hematopoietic cell transplantation survivorsSaro H Armenian, Dongyun Yang, Jennifer Berano Teh, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 18, 2012
Second primary malignancies after autologous hematopoietic cell transplantation for multiple myelomaAmrita Y Krishnan, Matthew Mei, Can-Lan Sun, et al.
Plos One|January 14, 2016
L1 Cell Adhesion Molecule-Specific Chimeric Antigen Receptor-Redirected Human T Cells Exhibit Specific and Efficient Antitumor Activity against Human Ovarian Cancer in MiceHao Hong, Christine E Brown, Julie R Ostberg, et al.
Blood Cancer Journal|July 12, 2023
Donor-derived CD19-targeted chimeric antigen receptor T cells in adult transplant recipients with relapsed/refractory acute lymphoblastic leukemiaIbrahim Aldoss, Samer K Khaled, Yan Wang, et al.
Blood|October 5, 2012
Cardiovascular risk factors in hematopoietic cell transplantation survivors: role in development of subsequent cardiovascular diseaseSaro H Armenian, Can-Lan Sun, Tabitha Vase, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 21, 2007
Phase II trial of a transplantation regimen of yttrium-90 ibritumomab tiuxetan and high-dose chemotherapy in patients with non-Hodgkin's lymphomaAmrita Krishnan, Auayporn Nademanee, Henry C Fung, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 1, 2014
Autologous transplantation for transformed non-Hodgkin lymphoma using an yttrium-90 ibritumomab tiuxetan conditioning regimenMatthew Mei, Marielle J Wondergem, Joycelynne M Palmer, et al.
Bone Marrow Transplantation|April 5, 2022
Genome-wide variants and polygenic risk scores for cognitive impairment following blood or marrow transplantationNoha Sharafeldin, Jianqing Zhang, Purnima Singh, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 8, 2017
Next-Generation Sequencing in Adult B Cell Acute Lymphoblastic Leukemia PatientsOlga Sala Torra, Megan Othus, David W Williamson, et al.
Pageof 50